Hosted on MSN2mon
Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers
MASH, or metabolic dysfunction-associated steatohepatitis, is a serious liver disease that’s caused by a buildup of fat that becomes inflamed despite a low intake of alcohol. It was formerly ...
Nature1y
From NAFLD to MAFLD: navigating the future of fatty liver treatment
Drawing on years of experience studying non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD), SMC has created the world’s first preclinical model with a type 2 diabetic ...